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Abstract
Background: Chronic pulmonary disease and skin/soft tissue infections due to non-tuberculous mycobacteria (NTM) of the
Mycobacterium chelonae-abscessus-massiliense group is an emerging health problem worldwide. Moreover, the cure rate
for the infections this group causes is low despite aggressive treatment. Post-surgical outbreaks that reached epidemic
proportions in Brazil recently were caused by M. massiliense isolates resistant to high-level disinfection with glutaraldehyde
(GTA). Understanding the differences in the virulence and host immune responses induced by NTM differing in their
sensitivity to disinfectants, and therefore their relative threat of causing outbreaks in hospitals, is an important issue.
Methodology/Principal Finding: We compared the replication and survival inside macrophages of a GTA-susceptible
reference Mycobacterium massiliense clinical isolate CIP 108297 and an epidemic strain from Brazil, CRM-0019, and
characterized the immune responses of IFNc knockout mice exposed to a high dose aerosol with these two isolates. CRM-
0019 replicated more efficiently than CIP 108297 inside mouse bone marrow macrophages. Moreover, the animals infected
with CRM-0019 showed a progressive lung infection characterized by a delayed influx of CD4+ and CD8+ T cells,
culminating in extensive lung consolidation and demonstrated increased numbers of pulmonary CD4+ Foxp3+ regulatory T
cells compared to those infected with the reference strain. Immunosuppressive activity of regulatory T cells may contribute
to the progression and worsening of NTM disease by preventing the induction of specific protective immune responses.
Conclusions/Significance: These results provide the first direct evidence of the increased virulence in macrophages and
mice and pathogenicity in vivo of the Brazilian epidemic isolate and the first observation that NTM infections can be
associated with variable levels of regulatory T cells which may impact on their virulence and ability to persist in the host.
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Introduction
Non-tuberculous mycobacteria (NTM) are ubiquitous in the
environment and are responsible for colonization, infection and
pseudo-outbreaksinhealth caresettingsthroughouttheworld.Most
NTM nosocomial outbreaks caused by rapidly growing mycobac-
teria (RGM) have involved the species M. abscessus, M. chelonae, M.
fortuitum and two recently recognized Mycobacterium species closely
related to M. abscessus: M. massiliense and M. bolletii [1,2]. These
pathogens can cause a wide range of clinical diseases including skin
and soft tissue infections, pulmonary, central nervous system and
disseminated infections [3,4,5,6,7,8,9,10,11,12,13,14]. While dis-
seminated infections caused by RGM essentially occur in
immunodeficient patients and pulmonary infections are widely
thought to be opportunistic and to occur in patients with struc-
tural lung disease (e.g., chronic obstructive pulmonary disease,
bronchiectasis, cystic fibrosis), numerous cases of skin and soft tissue
infections have been reported in otherwise immunocompetent
patients, caused by contaminated materials and invasive procedures
involving catheters, non-sterile surgical procedures, injections and
implantations of foreign bodies. Recent published reports [15,16]
and outbreaks in Brazil [13,17] suggest that the prevalence of
infections caused by these microorganisms is increasing and that
infections due to RGM are particularly problematic due to their
ubiquitous presence in hospitals’ water sources and the difficulty of
treating some of the infections they cause.
Following infection, very little is known about the host immune
response and what enables NTM to persist in host tissues. While
some NTM species, such as M. fortuitum and M. chelonae, can be
controlled by innate immunity [18,19], others like M. abscessus,
require adaptive immunity for efficient control of the infection
[19,20]. Our studies support the early occurrence of phagocytosis
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macrophages and dendritic cells [20,21]. Autocrine and paracrine
activation of dendritic cells by IL-12 p40 and migration of the
infected dendritic cells to the regional mediastinal lymph nodes
and subsequent mycobacterial antigen presentation to naive T
cells results in differentiation and further activation of effector T
cells. The accumulation in the lung of protective T cells capable of
expressing IFNc and TNFa are crucial for phagocyte activation
and intracellular killing [19,22]. The development of a pulmonary
granuloma is orchestrated by chemokines and cytokines produced
by local cells causing a continuous recruitment of lymphocytes,
macrophages, dendritic cells and granulocytes to the lung. Control
of the infection relies on this granulomatous response, which is an
organized cellular network acting to restrain NTM growth and
limit dissemination. In the context of M. tuberculosis persistence and
chronic disease, it has been shown that CD4+Foxp3+ regulatory T
cells are important for regulation of immunopathology [23,24,25].
The induction of CD4+Foxp3+ regulatory T cells has never been
reported in the case of Mycobacterium chelonae-abscessus-massiliense
group persistence and we propose it is one of the strategies
adopted by these microorganisms to enhance their persistence in
the human host. The immunosuppressive activity of regulatory T
cells may contribute to the progression and worsening of clinical
disease caused by NTMs by preventing the induction of specific
protective immune responses required to kill the bacterium.
The most important outbreaks – reaching epidemic proportions
- of nosocomial M. massiliense infections ever reported occurred
between 2004 and 2007 in Brazil. Interestingly, these outbreaks
seem to have been caused by one single strain of M. massiliense,
named BRA100 [12,13,17], which displays high level resistance to
glutaraldehyde (GTA), the chemical used for disinfection of
surgical instruments in all of the hospital sites that had confirmed
cases. While the resistance of this particular strain to high-level
disinfection has been advanced as the most likely reason for its
selection and dissemination across the country [12,13,17], the
unusual size of the outbreaks also suggests that BRA100 may
represent a particularly invasive and pathogenic strain of M.
massiliense. Such variability in pathogenicity among M. tuberculosis
clinical isolates has been well documented [23,26,27,28]. The
potential increase in pathogenicity of the epidemic BRA100
isolates is further supported by our recent findings that one of the
mechanisms through which RGM species develop high-level
resistance to GTA involves a remodeling of the composition and/
or organization of their cell surface susceptible of affecting their
intracellular survival and interactions with the host [29].
We undertook this study with the goal of comparing the M.
massiliense BRA100 epidemic isolate from Brazil to the glutaralde-
hyde-susceptible reference strain, M. massiliense CIP 108297, in
their abilities to replicate inside macrophages and to infect,
replicate, persist, induce organ pathology and immune responses
in mice.
Results
Morphological traits, disinfectant resistance and in vitro
growth characteristics of the M. massiliense isolates used
in this study
M. massiliense CIP 108297, the type strain used in this study, was
isolated from the sputum and the bronchoalveolar fluid of a
patient with hemoptoic pneumonia in France in 2004 [2]. CRM-
0019 is a BRA100 M. massiliense isolate from Brazil. It was
responsible for a nosocomial infection following hepatic tumor
resection by videolaparoscopy, the supposed index case of the
epidemic in the state of Rio de Janeiro [13]. The female patient
was 45 years old and presented the initial symptoms 90 days after
the videosurgery. She was submitted to clarithromycin-based
antimicrobial therapy and two additional laparotomies for
granuloma resections, resulting in complete recovery. M. massiliense
CIP 108297 and CRM-0019 display different pulse field gel
electrophoresis (PFGE) patterns confirming their lack of genetic
relationship [13]. The species assignment of both isolates was
confirmed by partial sequencing of their hsp65 and rpoB genes
(view Information S1).
The plating of CIP 108297 yielded uniform colonies interme-
diate between rough and smooth, as described earlier [2]. Plating
of CRM-0019 onto 7H11-OADC agar, in contrast, yielded a
mixed population of nonphotochromogenic rough and smooth
colonies. Suggestive of genetic instability, the culturing and re-
plating of individual rough and smooth CFUs led to colonies with
mixed phenotypes. Comparison of the growth rate of the two
strains in 7H9-OADC broth at 30uC revealed only a marginal
delay in growth associated to the BRA100 isolate during
exponential phase (view Information S1). Their growth rate on
7H11-OADC agar plates was comparable. Suspension suscepti-
bility tests confirmed the high level resistance of the BRA100
isolate, CRM-0019, to 2.2% GTA (view Information S1). Smooth
colonies of CRM-0019 displayed the same level of resistance as the
rough ones.
Growth of M. massiliense strains in mouse bone marrow
derived macrophages (BMDM)
We investigated the capacity of M. massiliense reference strain
CIP 108297 and the M. massiliense outbreak strain CRM-0019 to
grow in BMDM to evaluate their virulence. The growth of each
isolate was determined by the method of plating to measure
colony-forming units (CFU; Figure 1). The M. massiliense outbreak
strain CRM-0019 compared to the reference strain CIP 108297
demonstrated a significantly increased ability to replicate in
BMDM after 24 hours of infection and steadily increased
peaking at 7 days of infection. The reference strain CIP 108297
demonstrated nominal bacterial replication for 48 hours of
infection and thereafter began to steadily increase in bacterial
numbers in BMDM. Lastly, we evaluated the BMDM cellular
viability the percentage of propidium iodide positive dead cells
induced by the M. massiliense reference strain CIP 108297 and the
M. massiliense outbreak strain CRM-0019 was below 6.0% for the
BMDM (data not shown).
Bacterial loads in GKO mice
We chose a pulmonary infection model using interferon-gamma
(IFN-c) gene disrupted mice (GKO) to compare the two M.
massiliense strains in vivo for several reasons. Firstly, the reference
strain CIP 108297 was isolated from a patient with pulmonary
infection. Since our goal was to compare the pathogenicity of a
BRA100 isolate from Brazil to that of CIP 108297, we wanted to
ensure that the reference isolate was placed under conditions where
it would perform best in terms of establishing an infection.
Importantly, BRA100 isolates have been recovered both from
surgerypatients with skin and soft tissueinfectionsand from patients
with pulmonary infections not associated with the post-surgical
epidemic [30] indicating that they are pathogenic in pulmonary
infections as well. The second reason has to do with the fact that the
GKO model more closely reflects an RGM infection which would
occur in immunocompromised patients, a populationparticularly at
risk for NTM infections [15]. Clinical observations and/or genetic
studies in humans actually corroborate many of the findings in
animals in that those with cell-mediated immunodeficiency, genetic
defects in IFNc-interleukin-12 (IL-12) axis, and those individuals on
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pulmonary NTM infections, including the RGM [21]. In addition,
it has been shown that individuals infected with the human
immunodeficiency virus show reduced T cell IFNc production and
TH1 immunosuppression by CD4+Foxp3+ regulatory T cell
[31,32]. Lastly, the choice of using GKO mice instead of C57BL/
6 ones owes to the reported difficulty of infecting through the
aerosol route wild-type C57BL/6 mice that eliminate the bacteria
very rapidly, whereas GKO mice aerosolized with about 1,000
CFU develop a successful infection [33].
Followinga highdoseaerosol infection withM. massiliense reference
strain CIP108297andBrazilianoutbreak strainCRM-0019in GKO
mice (,1,000 bacilli per animal), the bacterial loads in the lungs
and spleens were quantified on days 1, 30 and 60 after the challenge.
Aerosol infection with the outbreak strain M. massiliense CRM-0019
resulted in a sustained infection in the lungs and spleens with more
than 10
3 organisms recovered from both organs at 60 days
(Figures 2A and 2B). In comparison, GKO mice infected with the
reference strain of M. massiliense showed complete clearance of this
strain in the lungs and spleens by day 60 (Figures 2A and 2B).
Lung histopathology in GKO mice after aerosol challenge
with Mycobacterium massiliense
Lung histopathology following high dose aerosol challenge with
the reference and outbreak M. massiliense strains was characterized
in GKO mice (Figure 3). At day 30 following the challenge, when
there was bacterial persistence in the lungs for both strains, lung
tissues demonstrated a local inflammatory response denoted by
peribronchiolar inflammatory infiltrates (Figure 3, panel A, A-D,
arrow). However, by day 60, while the reference M. massiliense
strain showed complete bacterial clearance and healthy lung tissue
(Figure 3, panel A, E–F), the lungs of the CRM-0019-infected
GKO mice showed large areas of consolidation (Figure 3, panel A,
G–H). In addition, CRM-0019-infected mice showed peribron-
chiolar inflammatory infiltrates with large aggregates of foamy
cells and the presence of macrophages with multiple intracellular
acid fast staining bacilli (Figure 3B).
Macrophage and dendritic cell cytokine expression
during Mycobacterium massiliense infection
Given the clear differences seen in cell influx indicated by the
histological analysis, we conducted a comparative flow cytometric
Figure 1. Increased intracellular replication of the Brazilian
outbreak strain M. massiliense CRM-0019 in mouse bone
marrow macrophages. Intracellular growth of M. massiliense
reference strain CIP 108297 and M. massiliense outbreak strain CRM-
0019 in BMDM. BMDM were infected with M. massiliense strains at a
MOI of 5, and the numbers of intracellular bacteria were determined
using the bacterial colony count method (CFU) immediately after
2 hours of infection or at 1, 2, 3, 4, 5, 6 and 7 days after infection. Values
shown are the mean 6 SD from two independent experiments. Growth
of the M. massiliense outbreak strain CRM-0019 was significantly higher
than the other isolate (*, P,0.05).
doi:10.1371/journal.pone.0024726.g001
Figure 2. Increased bacteria in the lungs and spleens of the Brazilian epidemic strain M. massiliense CRM-0019 infected IFNc-KO
mice. Bacterial counts in the lungs (A) and spleens (B), on days 1, 30 and 60 from IFNc-KO mice infected with a high dose aerosol of the epidemic
strain M. massiliense CRM-0019 (open circle) and M. massiliense CIP 108297 (solid square) were compared. Results are expressed as the average (n=5)
of the bacterial load in each group expressed as Log10CFU, 6 standard error mean (SEM). Student t-test, *p,0.050.
doi:10.1371/journal.pone.0024726.g002
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(CD11c+) populations from lungs and spleens of M. massiliense
CRM-0019-infected mice compared to CIP 108297-infected mice.
Figure 4 A shows representative dot plots of lung cells from the
isotype control, reference CIP 108297 and the outbreak M.
massiliense CRM-0019 strain after 30 days of infection in mice
primarily gated on CD11b+ macrophages cells expression of IL-
12. As shown in Figure 4 B and C, macrophages and dendritic
cells from the CRM-0019-infected mice showed reduced numbers
of lung and spleen IL-12 and TNFa producing macrophage and
dendritic cells compared to the reference strain CIP 108297.
CD4+ and CD8+ T cell cytokine expression during
Mycobacterium massiliense infection
We next sought to investigate the differences in the CD4+ and
CD8+ T cells in the lungs and spleens of mice infected with the
epidemic strain M. massiliense CRM-0019 compared to reference
strain CIP 108297 after 30 and 60 days of infection. We evaluated
CD4+ and CD8+ T cells ability to produce the protective cytokine
TNFa required for efficient granuloma formation [34]. We also
evaluated CD4+ and CD8+ T cells ability to induce immunosup-
pressive cytokines such as IL-4 which is considered to increase host
susceptibility to intracellular pathogens [20].
Figure 5 A shows representative dot plots of lung cells from the
isotype control, reference CIP 108297 and the outbreak M.
massiliense CRM-0019 strain after 30 days of infection in mice
primarily gated on CD4+ T cells expression of TNFa. Mice
infected with CRM-0019 showed significant reduced numbers of
lung and spleen TNFa–expressing CD4+ T cells by day 30 of
infection compared to the reference strain (Figure 5 B-C).
However, animals infected with the epidemic strain during
chronic infection showed similar level of TNFa–expressing
CD4+ and CD8+ T cells in the spleen as the reference strain
(Figure 5 C). The two types of infected mice did not differ in lung
and spleen IL-4–expressing CD4+ and CD8+ T cells (data not
shown).
CD4+Foxp3 regulatory T cell expression during
Mycobacterium massiliense infection
To try to understand these differences seen between the
epidemic strain CRM-0019 and the reference M. massiliense strain
CIP 108297, we performed studies in which we re-examined the T
cell response. Figure 6 A shows representative dot plots of lung
cells from the isotype control, reference CIP 108297 and the
outbreak M. massiliense CRM-0019 strain after 30 days of infection
in mice primarily gated on CD4+ T cells expression of Foxp3+.
The results in Figure 6 B clearly show an increased number of
CD4+Foxp3+IL-10+ T cells in the lungs and spleens of mice
infected with the epidemic strain compared to the reference strain
at both time points. In fact, compared to CIP 108297-infected
Figure 3. Lung histology from M. massiliense infected IFNc-KO mice. Panel A, A-H shows representative lung histopathology from the
M. massiliense CIP 108297- and epidemic CRM-0019-infected animals on day 30 and 60 of the infection. Tissue sections are stained with hematoxylin
and eosin. The lower photograph depicts the magnified region denoted by the square (upper photograph). CRM-0019-infected mice (panel A: D and
H) showed an increased rate of granuloma (arrows) progression and involvement of larger areas of the lung compared to the control mice (panel A: B
and E). Panel B shows representative lung acid fast staining bacilli at day 60 after M. massiliense CIP 108297 and CRM-0019 infection. Total
magnification, panel A [A, C, E, G] = 10x; panel A [B, D, F, H] = 20x; panel B = 100x.
doi:10.1371/journal.pone.0024726.g003
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numbers of both CD4
+Foxp3
+ T cells and CD4
+Foxp3
+ IL10+ T
cells in the lungs and spleens during the course of infection.
Discussion
Owing to its relatively recent recognition as a novel Mycobac-
terium species [2], not much is known about the virulence and
pathogenicity of M. massiliense. The limited information presently
available suggests that the clinical manifestations of the diseases
caused by M. massiliense in humans are similar to those caused by
M. abscessus [14]. The results of this study clearly show that M.
massiliense clinical isolates with different genetic backgrounds can
significantly differ in their ability to replicate and persist inside
macrophages and induce distinct immune responses contributing
to the different virulence phenotypes in mice. The Brazilian
epidemic BRA100 strain M. massiliense CRM-0019 clearly
replicates more efficiently than the reference strain CIP 108297
in mouse bone marrow macrophages resulting in rapid cell lysis. It
is also more virulent for GKO mice than is strain CIP 108297,
persisting in the lungs and spleens and inducing more severe lung
and spleen pathology. Mice infected with strain CIP 108297
eventually clear the infection showing an absence of residual bacilli
and organ pathology 60 days post-infection. Several reasons may
account for the enhanced persistence of CRM-0019 in vivo
including the increased ability of this isolate to replicate and
survive inside macrophages and, potentially, our novel observation
here that this particular M. massiliense isolate expands a regulatory
T cell response that attempts to dampen the progression of organ
pathology associated with bacterial persistence but also suppresses
the protective TNFa and IL-12 [TH1] response required for
mycobacterial containment and eventual elimination.
In this regard, we found evidence that immunodeficient GKO
mice administered the epidemic BRA100 strain M. massiliense
CRM-0019 through the aerosol route expand a weak TH1
response, compared to the reference strain CIP 108297. Recent
studies have shown that immunocompetent C57BL/6 and BALB/
c mice infected with a large intravenous dose of a M. massiliense
BRA100 isolate closely related to CRM-0019 developed a robust
TH1 response consisting of macrophage, dendritic cell and natural
killer cell activation, induced by IL-12 and IL-17 [35]. However,
there are important differences between their study and ours
which raise new interesting questions. First, they intravenously
infected their immunocompetent mice with a very large inoculum
Figure 4. Decreased macrophage and dendritic cell expression of IL-12 and TNFa in the lungs and spleens of IFNc-KO mice infected
with the epidemic strain M. massiliense CRM-0019. Mice infected with M. massiliense CIP 108297 (closed square) and the epidemic strain
M. massiliense CRM-0019 (open circle) were assayed by flow cytometry on days 30 and 60. Panel A shows representative dot plots of lung cells from
the isotype control, reference CIP 108297 and the outbreak M. massiliense CRM-0019 strain after 30 days of infection in mice primarily gated on
CD11b+ macrophages cells expression of IL-12. Panels B and C show the total number of macrophage (CD11b+) and dendritic (CD11c+) cells
expressing IL-12 or TNFa in the lungs (A) and spleens (B) of both types of infected mice. Results are expressed as the mean number of CD11b
+IL-12
+,
CD11b
+ TNFa
+,CD11c
+IL-12
+, CD11c
+ TNFa
+ (6 SEM, n=5) T cells in the lungs and spleens. Student t-test, *p,0.050.
doi:10.1371/journal.pone.0024726.g004
Increased Virulence in M. massiliense Infection
PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24726of M. massiliense CRM-0019 (1610
6 organisms per mice, with
concentration level reaching 10
7 CFU in the liver, spleen and
lungs [35]. Thus, although their murine model of intravenous
infection revealed important immunological findings, it may not
reflect the typical bacterial numbers nor immune responses elicited
by immunodeficient humans during a nosocomial, wound or
aerosol infection [7,21]. Prior studies have shown that increased
doses of NTM can induce increasingly robust immune responses
[20]. Second, an intravenous infection which kinetically spreads to
all organs rapidly causing rapid bacterial dissemination does not
reflect bacilli deposited in soft tissue during a surgical procedure
nor a pulmonary infection [36]. Our model was developed to use a
dose of bacteria and an immunodeficient animal model which best
reflects those individuals which generally become infected with
such opportunistic pathogens as those from the M. abscessus-M.
massiliense group.
The apparent lack of TH1 immunity during aerosol infection
with the outbreak strain M. massiliense CRM-0019 was due to
reduced numbers of CD11b
+ cells producing TNF-a and IL-12
cells at the site of infection. In addition, CD11c+ dendritic cells
were also expressing less TNF-a and IL-12. Importantly, in our
comparative evaluation of T cell responses in M. massiliense CRM-
0019 and CIP 108297-infected mice, we observed reduced
numbers of CD4+ T cells secreting TNFa in the lungs and
spleens of CRM-0019-infected mice at 30 days, while at the same
time increased numbers of CD4+Foxp3+IL-10
+ CD4 cells was
observed. This is the first observation that non-tuberculous
rapidly-growing mycobacteria are capable of inducing the
Figure 5. Decreased early CD4+ and CD8+ T cell expression of TNFa in the lungs and spleens of IFNc-KO mice infected with the
epidemic strain M. massiliense CRM-0019. Mice infected with an aerosol dose of M. massiliense CIP 108297 (closed square) and CRM-0019 (open
circle) were assayed by flow cytometry on days 30 and 60. Panel A shows representative dot plots of lung cells from the isotype control, reference CIP
108297 and the outbreak M. massiliense CRM-0019 strain after 30 days of infection in mice primarily gated on CD4+ T cells expression of TNFa. Panels
B and C show decreased CD4+ and CD8+ T cell expression of TNFa in the lungs (A) and spleens (B) of mice infected with the epidemic strain CRM-
0019 compared to CIP 108297 (6 SEM, n=5). Results are expressed as the mean number of CD4
+TNFa
+, CD8
+TNFa
+,( 6 SEM, n=5) T cells in the
lungs and spleens. Student t-test, *p,0.050.
doi:10.1371/journal.pone.0024726.g005
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reports have shown that clinical isolates of M. tuberculosis vary in
their ability to induce regulatory T cells with possible consequenc-
es on virulence and host protective immunity [23,37]. Moreover,
there is evidence that patients with active tuberculosis have raised
levels of circulating regulatory T cells [38,39]. Thus, regulatory T
cell induction may be inherent in mycobacterial host immunity
and not just responding to the acute lung damage caused by highly
virulent M. tuberculosis. Our study suggests that IL-10, a product of
regulatory T cells as well as macrophages, may play a role in
maintaining the stability of persistent NTM disease as has also
been suggested in the case of Bordetella pertussis infection [40].
A likely correlate of our important findings is that the ability of
some M. massiliense isolates and, perhaps, closely related Mycobac-
terium species, to persist in vivo through increased resistance to the
bactericidal mechanisms of macrophages and the modulation of T
Figure 6. Increased CD4+ Foxp3+IL-10+ regulatory T cell expression in the lungs and spleens of IFNc-KO mice infected with M.
massiliense CRM-0019. Lung cells obtained from mice infected with M. massiliense CIP 108297 (closed square) and CRM-0019 (open circle) were
assayed by multi-parametric flow cytometry on days 30 and 60. Panel A shows representative dot plots of lung cells from the isotype control,
reference CIP 108297 and the outbreak M. massiliense CRM-0019 strain after 30 days of infection in mice primarily gated on CD4+ T cells expression of
Foxp3+. Panel B shows that mice infected with M. massiliense CRM-0019 had a significant increase in CD4+Foxp3+ and CD4+Foxp3+ IL-10+ regulatory
T cells in the lungs and spleens at 30 and 60 days of infection compared to M. massiliense CIP 108297-infected mice. Results are expressed as the
mean number of CD4+Foxp3+ and CD4
+Foxp3+ IL-10+ (6 SEM, n=5) T cells in the lungs and spleens. Student t-test, *p,0.050.
doi:10.1371/journal.pone.0024726.g006
Increased Virulence in M. massiliense Infection
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24726regulatory cells may account, at least in part, for the extreme
difficulty of treating the infections they cause [7] and the lack of
correlation between their susceptibility to drugs under axenic
conditions and in vivo.
At present the only available vaccine against tuberculosis,
M. bovis Bacillus Calmette-Gue ´rin (BCG), has proven unreliable in
being able to protect against pulmonary tuberculosis in adults [41].
It has been proposed by some epidemiological studies that BCG
protects the host in countries where low levels of environmental
NTM exposure occurs compared to lack of BCG protection in
developing countries where high levels of environmental NTM
exposure occurs [42]. We propose that the widely varying degrees
of BCG efficacy present in different studies may be due to
environmental NTM exposure and pre-sensitization of individuals
to regulatory T cell expansion resulting in cross reactivity during
M. tuberculosis [24] disease.
Further research is required to link the virulence and molecular
mechanisms underlying the increased pathogenicity of BRA100 M.
massiliense epidemic isolates, whether related to changes in surface
composition under the selective pressure of GTA disinfection or
otherwise, which are presently being investigated in our laboratories.
Materials and Methods
Bacterial Cultures
CIP 108297 (the M. massiliense type strain) [2] and the BRA100
isolate, CRM-0019 [13], were routinely grown at 30uC in liquid
Middlebrook 7H9-OADC medium (Difco) supplemented with
0.05% Tween 80 or on solid Middlebrook 7H11-OADC medium.
GTA-susceptibility testing
The susceptibility of M. massiliense to glutaraldehyde in suspension
tests was determined as described by Griffiths et al. [43].
Mice
Specific-pathogen-free female GKO mice, from 6 to 8 weeks
old, were purchased from the Jackson Laboratories, Bar Harbor,
Maine. Mice were maintained in the Biosafety Level III animal
laboratory at Colorado State University, and were given sterile
water, mouse chow, bedding, and enrichment for the duration of
the experiments. The specific pathogen-free nature of the mouse
colonies was demonstrated by testing sentinel animals. All
experimental protocols were approved by the Animal Care and
Usage Committee of Colorado State University. The CSU animal
assurance welfare number is A3572-01.
Experimental infection of BMDM and bacterial
enumeration
Macrophages were infected with mycobacteria, and 2 hours
later, the monolayers were washed to remove extracellular bacilli.
The numbers of intracellular mycobacteria were measured by
plating. Briefly, monolayers were washed at each time point to
remove extracellular bacilli and 1 ml double-distilled H2O
containing 0.05% Tween 80 was added to monolayers and
incubated for 10 min to lyse macrophages. After passing through a
26-gauge needle five times, the lysates were serially diluted and
plated onto Middlebrook 7H11 agar plates. Monolayers that
weren’t lysed were replenished with fresh medium.
Cellular viability assays
BMDM cell death was assayed by trypan blue exclusion and
determined by flow cytometry using BD
TM Viability Counting
Beads, as described by the manufacturer (BD PharMingen, San
Jose, CA USA 95131) cell viability-staining methods [32].
Experimental infections in mice
Mice were challenged with reference strain Mycobacterium
massiliense CIP 108297 and a clinical epidemic BRA100 strain,
Mycobacterium massiliense CRM-0019, using a Glas-Col (Terre
Haute, Inc.) aerosol generator calibrated to deliver either a HDA
of ,1,000 bacilli per animal. At days 1, 30 and 60 following
infection, bacterial loads in the lungs and spleen, lung histology,
and mononuclear and lymphocytic cellular expressions were
determined. Bacterial counts were determined by plating serial
dilutions of homogenates of lungs on nutrient 7H11 agar and
counting colony-forming units after 5-10 days incubation at 30uC.
A total of five animals were infected for each time point.
Histological analysis
The accessory lobe of the lung from each mouse was fixed with
10% formalin in phosphate buffered saline (PBS). Tissue sections
were stained using haematoxylin and eosin and acid-fast stains as
previously reported [20,23].
Lung cell digestion
Briefly, single cell suspensions were prepared as described
previously [20]. Lungs and spleens were aseptically removed,
teased apart and treated with a solution of deoxyribonuclease IV
(DNAse) (Sigma Chemical, 30 mg/ml) and collagenase XI (Sigma
Chemical, 0.7 mg/ml) for 45 min at 37uC. To obtain a single-cell
suspension, the organs were gently passed through cell strainers
(Becton Dickinson, Lincoln Park, NJ). The remaining erythrocytes
were lysed with Gey’s solution (0.15 M NH4Cl, 10 mM KHCO3)
and the cells were washed with Dulbecco’s modified Eagle’s
minimal essential medium. Cell suspensions from each individual
mouse were incubated with monoclonal antibodies labeled with
fluorescein isothiocyanate (FITC), phycoerythrin (PE), peridinin
chlorophyll-a protein (PerCP), or allophycocyanin (APC) at 4uC
for 30 minutes in the dark as described previously [20]. Total cell
numbers were determined by flow cytometry using BD
TM Liquid
Counting Beads, as described by the manufacturer (BD PharMin-
gen, San Jose, CA USA 95131). All analyses were performed with
an acquisition of at least 100,000 total events.
Intracytoplasmic cytokine staining
Cells were first stained for cell surface markers as indicated
above and thereafter the same cell suspensions were prepared for
intracellular staining as described before [20,23]. For flow
cytometry analysis, single-cell suspensions of lung from each mice
were re-suspended in PBS (Sigma-Aldrich) containing 0.1% of
Sodium Azide (PBS+Na/Az). Cells were incubated in the dark for
25 min at 37uC with pre-determined optimal titrations of specific
antibody (directly conjugated to fluorescein isothiocyanate (FITC),
phycoerythrin (PE), peridin-cholorophyll-protein (PerCP), allo-
phycocyanin (APC), Pacific Blue, Alexa 700); or after biotin
antibody incubations washed and incubated for 25 minutes more
with streptavidin Qdot800 (Invitrogen), followed by two washes in
PBS containing 4% sodium azide. Measurement of intracellular
cytokines was conducted by pre-incubating lung cells with
monensin (3 mM) (Golgi Stop, BD PharMingen), anti-CD3 and
anti-CD28 (both at 0.2 mg/10
6 cells) for 4 h at 37uC, 5% CO2.
The cells were then surface stained, incubated for 30 minutes at
37uC, washed then fixed and permeabilized with Perm Fix/Perm
Wash (BD Pharmingen). Finally, the cells were stained with
intracellular Foxp3 (FJK-16s), IL-12 (clone REM-11) TNFa (clone
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further 30 min. All the samples were run on a Becton Dickinson
LSR-II and data were analyzed using FACSDiva v5.0.1 software.
Cells were gated on lymphocytes based on characteristic forward
and side scatter profiles. Individual cell populations were identified
according to their presence of specific fluorescent-labeled anti-
bodies. All the analyses were performed with a minimum
acquisition of 100,000 events. Our laboratory routinely uses the
Becton-Dickinson Company LSR II flow cytometer fluorescence
minus one (FMO) technology comparing the isotype control verses
the fluorescence of the subpopulations evaluated as an internal
quality control in addition to the standard isotype verses isotype
control. We have verified that no significant differences exist in
values between our isotype verse isotype control compared to our
isotype verses the fluorescence of the subpopulations evaluated in
our study.
Statistical analysis
Data are presented using the mean values from 5 mice per
group and from values from replicate samples and duplicate or
triplicate assays. The Student t-test test was used to assess statistical
significance between groups of mice.
Supporting Information
Information S1 (A) Partial sequencing of the hsp65 and
rpoB genes of M. massiliense CIP 108297 and CRM-
0019. The corresponding sequences of M. abscessus ATCC 19977
are included in the alignments as a reference. PCR amplification
were performed as described by Ringuet et al. (1999) and Kirshner
et al. (1993) (see references below). (B) Growth rates of
M. massiliense CIP 108297 and CRM-0019 in 7H9-
OADC-Tween 80 broth at 306C. M. massiliense CIP 108297
(diamonds); M. massiliense CRM-0019 (rectangles). (C) GTA
susceptibility of M. massiliense CIP 108297 and CRM-
0019. Results are expressed as CFU counts upon exposure of the
test organisms to 2.2% GTA (under the formulated form of
CidexH, Johnson & Johnson) for 0 to 30 min. M. massiliense CIP
108297 (diamonds); M. massiliense CRM-0019 (rectangles).
(PDF)
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